Procedure Guideline for Myocardial Perfusion Imaging 3.3
D. Radiopharmaceuticals. The following single-photon-emitting radiopharmaceuticals are FDA-approved for use as myocardial perfusion tracers: 201 Tl-chloride, 99m Tc-sestamibi, and 99m Tc-tetrofosmin. The following positron-emitting radiopharmaceuticals are approved for use as myocardial perfusion tracers: 82 Rb and 13 N-ammonia. FDA recommendations for the maximum administered dose for a ...
Journal of Nuclear Medicine Technology
JNMT is the only peer-reviewed publication dedicated to nuclear medicine technology. Published quarterly, each issue features continuing education articles written by leading educators in nuclear medicine technology as well as news and updates on practice, licensure, and credentialing for nuclear medicine technologists.
SNM Practice Guideline for Hepatobiliary Scintigraphy 4.0
2010年12月1日 · III. DEFINITIONS. Hepatobiliary scintigraphy is a radionuclide diagnostic imaging study (including planar imaging, SPECT, or hybrid imaging such as SPECT/CT) that evaluates hepatocellular function and the biliary system by tracing the production and flow of bile from the formative phase in the liver, and its passage through …
Procedure Guideline for Adult Solid-Meal Gastric-Emptying Study 3.0
The purpose of this guideline is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the results of gastric-emptying and motility studies in adults. Radionuclide studies of gastric emptying and motility are the most comprehensive and physiologic studies of gastric motor function available. The studies are noninvasive, use a physiologic meal (solids ...
Consensus Recommendations for Gastric Emptying Scintigraphy: A …
This consensus statement from the members of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine recommends a standardized method for measuring gastric emptying (GE) by scintigraphy. A low-fat, egg-white meal with imaging at 0, 1, 2, and 4 h after meal ingestion, as described by a published multicenter protocol, provides standardized information about ...
Gated Myocardial Perfusion SPECT: Basic Principles, Technical …
2004年12月1日 · Electrocardiographically gated myocardial perfusion SPECT (GSPECT) is a state-of-the-art technique for the combined evaluation of myocardial perfusion and left ventricular function within a single study. It is currently one of the most commonly performed cardiology procedures in a nuclear medicine department. Automation of the image processing and quantification has made this technique highly ...
Artifacts and Pitfalls in Myocardial Perfusion Imaging
Myocardial perfusion imaging (MPI) is an important imaging modality in the management of patients with cardiovascular disease. MPI plays a key role in diagnosing cardiovascular disease, establishing prognosis, assessing the effectiveness of therapy, and evaluating viability. However, MPI is a complex process, subject to a variety of artifacts and pitfalls, which may limit its …
SNMMI Procedure Standard for Bone Scintigraphy 4.0
2018年12月1日 · III. DEFINITIONS. Bone scintigraphy is the general term for a diagnostic study used to evaluate the distribution of osteoblastic activity in the body, whether this activity is benign, malignant, or physiologic. There are 4 types of bone scintigraphy: Whole-body bone planar scintigraphy is performed to obtain anterior and posterior static images of the entire axial and appendicular skeleton.
Cardiac Amyloidosis Imaging, Part 3: Interpretation, Diagnosis, and ...
2023年6月1日 · Cardiac amyloidosis was thought to be rare, undiagnosable, and incurable. However, recently it has been discovered to be common, diagnosable, and treatable. This knowledge has led to a resurgence in nuclear imaging with 99mTc-pyrophosphate—a scan once believed to be extinct—to identify cardiac amyloidosis, particularly in patients with heart failure but preserved ejection fraction.
Procedure Guideline for the Use of Radiopharmaceuticals 4.0
A. Radiopharmaceuticals. Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the ...